SVA — Sinovac Biotech Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareMicro Cap

Annual balance sheet for Sinovac Biotech, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	R2021 December 31st	R2022 December 31st	R2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	20-F	20-F	20-F	20-F	20-F
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	13,415	10,532	11,019	9,949	5,971
Net Total Accounts Receivable
Net Total Receivables	970	570	425	322	313
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	14,938	11,305	11,597	10,645	7,064
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	970	1,048	998	897	716
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	16,759	14,031	13,612	12,337	8,542
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	2,519	1,256	1,293	1,452	1,540
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	7,764	5,540	5,296	4,075	4,103
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	8,995	8,491	8,316	8,262	4,439
Total Liabilities & Shareholders' Equity	16,759	14,031	13,612	12,337	8,542
Total Common Shares Outstanding